Filing Details
- Accession Number:
- 0001209191-22-057942
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-18 17:17:54
- Reporting Period:
- 2022-09-27
- Accepted Time:
- 2022-11-18 17:17:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-27 | 65 | $2.57 | 52,881 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-28 | 65 | $2.52 | 52,946 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-29 | 65 | $2.51 | 53,011 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-30 | 65 | $2.61 | 53,076 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-03 | 65 | $2.54 | 53,141 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-04 | 65 | $2.61 | 53,206 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-05 | 65 | $2.58 | 53,271 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-06 | 65 | $2.65 | 53,336 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-07 | 65 | $2.66 | 53,401 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-10 | 65 | $2.53 | 53,466 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-11 | 65 | $2.48 | 53,531 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-12 | 65 | $2.49 | 53,596 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-13 | 65 | $2.38 | 53,661 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-14 | 65 | $2.31 | 53,726 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-17 | 65 | $2.33 | 53,791 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-18 | 65 | $2.46 | 53,856 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-19 | 65 | $2.42 | 53,921 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-20 | 65 | $2.44 | 53,986 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-21 | 65 | $2.49 | 54,051 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-24 | 65 | $2.38 | 54,116 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-25 | 65 | $2.44 | 54,181 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-26 | 65 | $2.42 | 54,246 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-27 | 65 | $2.49 | 54,311 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-28 | 65 | $2.52 | 54,376 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-31 | 65 | $2.54 | 54,441 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.